A Primer On Endpoints: Global Blood Therapeutics
December 06, 2016 at 11:00 AM EST
The 90 mg GBT440 data presented by Global Blood Therapeutics Inc (NASDAQ: GBT) at the American Society of Hematology meeting showed ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.